Our Mission & Vision
The ANZCCP is a professional membership body for cannabinoid medicine practitioners. Our vision is to guide the practice of Cannabinoid Medicine and better the lives of patients.
Our Objectives
- Patient-centred clinical perspectives to the entire medical cannabis eco-system
- Provide accredited clinician education and promote professional standards for the practice of integrative and cannabinoid medicine
- Resources for practitioner support, advocacy and collegiality
- Policy advice
- Support for research
ANZCCP Board
Dr Adele Hosseini
President
Dr. Adele Hosseini is a pharmacist with a PhD and over 25 years of experience in leadership, global clinical research, regulatory affairs and university lecturing, with exposure across pharmaceuticals, clinical research organisation, medical devices, and academia. Pioneering across various industries in Australia including medicinal cannabis and psychedelics industry led Bod Australia’s Medical Advisory Board and research program and is a member of the board of directors of a Canadian medicinal cannabis company. Over the last few years, Dr. Hosseini has developed a deep understanding of medicinal cannabis and continues to development new strategic directions and development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications for public health benefit. She is an active industry contributor helping to build knowledge and shape the direction and future of the global pharmaceutical medicinal cannabis industry.
Dr Orit Holtzman
Vice President
Dr Orit Holtzman holds a Bachelor of Science in biology and psychology from the University of Tel Aviv (Summa Cum Laude), a PhD in neuroscience from the University of NSW and an MBBS from the Sydney Medical School at the University of Sydney.
She is the Co-founder and Director of Leura Wellness, where she practices functional medicine with a focus on cannabinoid medicine and is the Co-Founder and President of the Australian and New Zealand College of Cannabinoid Practitioners (ANZCCP). Dr Holtzman is one of Australia’s most experienced medicinal cannabis prescribers and educators. She is a TGA approved medicinal cannabis authorised prescriber for multiple indications.
Dr Imran Khan
Secretary & Founding Board Member
Doctor Imran Khan is a founding board member for the ANZCCP. He completed his medical training at The Sheffield School of Medicine (UK) and has over two decades of clinical and leadership experience in the UK, Australia & Qatar. He is serving as the Medical Director of WeCan Holistic Care. As a meritorious member of the Royal College of General Practitioners (UK) for 9 years, he was awarded full accreditation with the RACGP after moving to Sydney. He worked in the Manchester United Football club medical team for 9 years and currently practices out of the Warringah Medical & Dental Centre in Brookvale NSW.
Lisa Dick
Board member
Lisa Dick has been a registered nurse for over 30 years, specialising in aged care, community health, urological conditions, chronic disease, pain and continence management. Lisa was endorsed as a Nurse Practitioner in 2016 after completing her Masters of Nurse Practitioner at The University of Melbourne. She has worked as a Nurse Practitioner in a variety of different settings including in both public and private health services. Lisa is a member of the Australian College of Nurse Practitioners (ACNP). During her career Lisa has been honoured to represent the ACNP as the Victorian Chapter Chair for a 2 year term. In 2021 Lisa commenced specialising in medicinal cannabis. She has always had an interest in plant-based medicine and since she was given the opportunity to provide treatment with whole plant products, there has been no looking back. Lisa enjoys every opportunity to attend and participate in educational events on Medicinal Cannabis and often presents at ACNP Conferences to her fellow colleagues.
Dr Michael Murphy
Board Member
Dr. Michael Murphy has dedicated the last 15 years to Emergency Medicine in New Zealand. A graduate in Medicine and Pharmacology from the UK, Dr. Murphy has cultivated particular interests in resuscitation and toxicology within acute settings. During the COVID-19 pandemic, he remained on the frontline while also playing a pivotal role in establishing CannaPlus+, New Zealand’s premier medicinal cannabis clinic, as its Clinical Director. Recently, Dr. Murphy joined the ANZCCP and RNZCUC, attending the inaugural ANZCCP conference this year. Driven by a passion for health optimisation, his focus is on reducing the pharmacological burden on patients, healthcare services, and society at large.